首页> 外国专利> METHOD FOR QUANTITATIVELY DETERMINING AN ANTIBODY HAVING THE ABILITY TO INHIBIT THE ACTIVITY OF A REVERSE TRANSCRIPTASE

METHOD FOR QUANTITATIVELY DETERMINING AN ANTIBODY HAVING THE ABILITY TO INHIBIT THE ACTIVITY OF A REVERSE TRANSCRIPTASE

机译:定量确定具有抑制逆转录酶活性的抗体的方法

摘要

Disclosed is a method for quantitatively determining anantibody, contained in a biological sample, having the ability toinhibit the activity of a reverse transcriptase derived from anHIV, comprising: reacting a hybridization product, immobilized ona solid phase, of a primer consisting essentially of oligodeox-ythymine nucleotide and an RNA template consisting essentially ofadenine ribopolynucleotide with a reverse transcriptase derivedfrom HIV, to thereby bind the reverse transcriptase to the hybrid-ization product; conducting a synthesis of a DNA complementary tothe RNA template from a deoxymononucleotide triphosphate in thepresence of the reverse transcriptase activity-inhibiting anti-body; and measuring the amount of the synthesized DNA and quanti-tatively determining the above-mentioned antibody, based on themeasured amount of the synthesized DNA. The method of the presentinvention can be performed with ease and with high reproducibilityin classifying and quantitatively determining the antibodiesagainst the epitopes of a viral reverse transcriptase. By themethod of the present invention, not only the virus having mutatedduring a latent period thereof, and the properties which the virusexhibits as a result of the mutation, but also a virus having ac-quired drug resistance as a result of the administration of thedrugs to the host, can be studied by quantitatively determiningthe antibodies. Further, it has also become possible to accurate-ly and promptly determine the changes in the infected host, suchas the change in the ability to produce antibodies, which occur inaccordance with the progression of illness.
机译:公开了一种用于定量地确定目标的方法。生物样品中包含的抗体具有抑制源自HIV,包括:使杂交产物发生反应,固定在基本上由寡聚脱氧核糖核酸组成的引物的固相胸腺嘧啶核苷酸和RNA模板,主要由带有逆转录酶的腺嘌呤核糖多核苷酸从而将逆转录酶与杂合体结合产品化;进行与以下分子互补的DNA的合成脱氧单核苷酸三磷酸中的RNA模板存在逆转录酶抑制活性身体;并测量合成的DNA量并定量根据抗体确定上述抗体量的合成DNA。现在的方法本发明可以容易地且以高再现性进行在对抗体进行分类和定量确定中对抗病毒逆转录酶的表位。由本发明的方法,不仅病毒已经突变在其潜伏期,以及该病毒的特性表现为突变的结果,但也有带有ac-由于服用该药物而导致的耐药性药物可以通过定量确定来研究抗体。此外,还可以精确地-及时确定感染主机的变化,例如作为产生抗体的能力的变化,根据疾病的进展。

著录项

  • 公开/公告号CA2221769C

    专利类型

  • 公开/公告日2003-07-01

    原文格式PDF

  • 申请/专利权人 ASAHI KASEI KOGYO KABUSHIKI KAISHA;

    申请/专利号CA19962221769

  • 发明设计人 ODAWARA FUMITOMO;

    申请日1996-05-24

  • 分类号C12Q1/68;C12Q1/48;G01N33/573;C12Q1/70;

  • 国家 CA

  • 入库时间 2022-08-21 23:58:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号